Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

900
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
900
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.0K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.0K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

174
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
174

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential anterior ischaemic optic neuropathy associated with angioid streaks and sphenoid fibrous dysplasia.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026
Same author

Online circular contrast perimetry: Tablet validation study against desktop test and standard automated perimetry.

Optometry and vision science : official publication of the American Academy of Optometry·2026
Same author

Online Circular Contrast Perimetry: Validity and Repeatability of Home Performance.

Journal of glaucoma·2025
Same author

Comparing Online Circular Contrast Perimetry and the Esterman Visual Field Test in Glaucoma for Driving-relevant Vision.

Journal of glaucoma·2025
Same author

Scedosporium and Cutibacterium skull base osteomyelitis complicated by blindness from fulminant papilloedema.

The New Zealand medical journal·2025
Same author

The carbon footprint of transperineal prostate biopsy.

BJUI compass·2025

Related Experiment Video

Updated: Dec 28, 2025

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.7K

Health Economic Analysis in Glaucoma.

Inhae Park1, Jesse Gale2,3, Simon E Skalicky4

  • 1Bentley & Sue Optometrists, Upper Hutt.

Journal of Glaucoma
|February 14, 2020
PubMed
Summary

Glaucoma care is cost-effective, but measuring treatment benefits (utility) over short periods is challenging. Improved methods are needed to assess glaucoma treatment value and support innovation in eye care services.

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.7K
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.7K

Related Experiment Videos

Last Updated: Dec 28, 2025

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.7K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.7K
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.7K

Area of Science:

  • Ophthalmology
  • Health Economics
  • Quality of Life Research

Background:

  • Glaucoma services face increasing demand, necessitating cost-effectiveness analyses for resource allocation.
  • Quantifying the benefits of glaucoma treatment, such as preventing vision loss and maintaining quality of life, is crucial.
  • Utility, a metric for health benefits, is difficult to measure accurately in short-term clinical trials for glaucoma.

Purpose of the Study:

  • To highlight the challenges in measuring the cost-effectiveness of glaucoma treatments.
  • To discuss the difficulties in quantifying utility changes in short-term glaucoma studies.
  • To emphasize the need for improved methods for utility measurement in glaucoma.

Main Methods:

  • Review of current challenges in glaucoma service cost-effectiveness.
  • Analysis of utility measurement in short-term clinical trials for glaucoma.
  • Discussion of the broader economic impact of glaucoma beyond direct medical costs.

Main Results:

  • Short-term clinical trials (up to 3 years) struggle to demonstrate significant utility differences between glaucoma treatments.
  • Estimating the full range of costs associated with glaucoma is complex and imprecise.
  • The inability to reliably measure short-term utility changes hinders the adoption of new glaucoma innovations.

Conclusions:

  • While the long-term cost-effectiveness of glaucoma care is established, short-term measurement limitations impede innovation.
  • Developing more sensitive and specific utility measurement approaches is essential for glaucoma treatment evaluation.
  • Addressing these measurement challenges will facilitate better resource allocation and adoption of advancements in glaucoma management.